Journal of the American Academy of Child and Adolescent Psychiatry Reaches Its Highest Impact Factor

Washington, D.C., August 22, 2011 - For the first time in its fifty year history, the Impact Factor (IF) of Journal of the American Academy of Child and Adolescent Psychiatry (JAACAP) has topped the 5.0 threshold, as reported in the recently released 2010 Journal Citation Reports® published by Thomson Reuters.

JAACAP’s impressive 2010 IF of 5.148 has gone up from 4.983 as reported for 2009. JAACAP now ranks 13th of 126 psychiatry journals and 2nd of 107 pediatrics journals listed in the 2010 Journal Citation Reports®. 

The IF reflects the citation rate per article of a scientific journal and is widely regarded as one of the most important metrics in scholarly publishing. The 2010 IF is calculated as all citations in 2010 divided by the number of citable items published in the journal in 2008 and 2009.

On learning of the new milestone, Editor-in-Chief Andrés Martin, M.D., M.P.H. noted, “The journal’s strong IF serves as a reflection of the significant dedication of our editorial team and reviewers, and of the outstanding scientific quality of our authors’ contributions.”

The American Academy of Child and Adolescent Psychiatry can take pride in the strong scientific standing and visible electronic presence of its flagship scholarly journal ( The journal is committed to advancing the science of pediatric mental health and promoting the care of youth and their families and JAACAP’s editors encourage authors to submit their cutting edge research in support of this important mission.

# # #

Notes to editors
For further information, please contact Rebecca Jensen, Executive Editor, JAACAP, or + 1 202 966 7300 extension 112. Contact Chris J. Pfister at to obtain a copy or to schedule an interview.

About the Journal of the American Academy of Child and Adolescent Psychiatry
The Journal of the American Academy of Child and Adolescent Psychiatry (JAACAP) is the official publication of the American Academy of Child and Adolescent Psychiatry. JAACAP is the leading journal focusing exclusively on today's psychiatric research and treatment of the child and adolescent. Published twelve times per year, each issue is committed to its mission of advancing the science of pediatric mental health and promoting the care of youth and their families.

The journal's purpose is to advance research, clinical practice, and theory in child and adolescent psychiatry. It is interested in manuscripts from diverse viewpoints, including genetic, epidemiological, neurobiological, cognitive, behavioral, psychodynamic, social, cultural, and economic. Studies of diagnostic reliability and validity, psychotherapeutic and psychopharmacological treatment efficacy, and mental health services effectiveness are encouraged. The journal also seeks to promote the well-being of children and families by publishing scholarly papers on such subjects as health policy, legislation, advocacy, culture and society, and service provision as they pertain to the mental health of children and families.

About Elsevier

Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Elsevier Research Intelligence,and ClinicalKey—and publishes over 2,200 journals, including The Lancet and Cell, and over 25,000 book titles, including a number of iconic reference works.

The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Media contact
Chris J. Pfister
+1 215 239 3266